VariantSurvival: a tool to identify genotype-treatment response.

For a number of neurological diseases, such as Alzheimer's disease, amyotrophic lateral sclerosis, and many others, certain genes are known to be involved in the disease mechanism. A common question is whether a structural variant in any such gene may be related to drug response in clinical trials and how this relationship can contribute to the lifecycle of drug development. To this end, we introduce VariantSurvival, a tool that identifies changes in survival relative to structural variants within target genes.